Researchers are exploring new ways to prevent the harmful effects of senescent cells that persist after cancer treatment. These aged cells, which stop dividing but remain active, can release inflammatory signals that promote tumor recurrence and other health issues. Scientists are investigating drugs known as senolytics, which selectively target and remove these cells, potentially reducing the risk of cancer relapse and improving long-term patient outcomes.
By eliminating senescent cells, researchers hope to enhance the effectiveness of cancer therapies and mitigate side effects associated with traditional treatments like chemotherapy and radiation. Early studies suggest that addressing cellular senescence could be a key factor in preventing cancer from returning and improving overall patient health. Further clinical trials are needed to confirm the safety and efficacy of these new approaches, but they offer a promising strategy for post-cancer care. Click for More Details
